Ligand Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.About LGND
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV.
CEOTodd Christopher Davis
CEOTodd Christopher Davis
Employees68
Employees68
HeadquartersJupiter, Florida
HeadquartersJupiter, Florida
Founded1987
Founded1987
Employees68
Employees68
LGND Key Statistics
Market cap2.96B
Market cap2.96B
Price-Earnings ratio-38.48
Price-Earnings ratio-38.48
Dividend yield—
Dividend yield—
Average volume464.73K
Average volume464.73K
High today$155.28
High today$155.28
Low today$150.99
Low today$150.99
Open price$155.28
Open price$155.28
Volume158.36K
Volume158.36K
52 Week high$157.54
52 Week high$157.54
52 Week low$93.58
52 Week low$93.58
LGND News
Seeking Alpha 4d
Ligand prices $400M convertible debt offeringHealthcare Ligand prices $400M convertible debt offering Aug. 12, 2025 12:25 AM ET Ligand Pharmaceuticals Incorporated (LGND) Stock By: Preeti Singh, SA News Ed...
Seeking Alpha 4d
Ligand Pharmaceuticals to offer $400M convertible senior notes in private placementLigand Pharmaceuticals (NASDAQ:LGND) announced on Monday an intent to offer $400M of convertible senior notes in a private placement to institutional buyers. S...
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own LGND. This list is generated using Robinhood data, and it’s not a recommendation.